Clinical efficacy, safety, and trial results may be compromised with current best estimate dosing regimens of hydroxychloroquine for treatment of COVID-19 patients
Marsot A & Thirion D
April 4, 2020
Comment : A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Kim AHJ et al. 30 March 2020
Comments